Files in this item
ISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans
Item metadata
dc.contributor.author | Vasou, Andri | |
dc.contributor.author | Nightingale, Katie | |
dc.contributor.author | Cetkovská , Vladimira | |
dc.contributor.author | Scheler, Jonathan | |
dc.contributor.author | Bamford, Conor G. G. | |
dc.contributor.author | Andrejeva, Jelena | |
dc.contributor.author | Rowe, Jessica C. | |
dc.contributor.author | Swatek, Kirby N. | |
dc.contributor.author | Schwarz-Linek, Ulrich | |
dc.contributor.author | Randall, Richard E. | |
dc.contributor.author | McLauchlan, John | |
dc.contributor.author | Weekes, Michael P. | |
dc.contributor.author | Bogunovic, Dusan | |
dc.contributor.author | Hughes, David J. | |
dc.date.accessioned | 2025-02-17T10:30:27Z | |
dc.date.available | 2025-02-17T10:30:27Z | |
dc.date.issued | 2025-02-11 | |
dc.identifier | 313643056 | |
dc.identifier | f2a583f9-9386-4b6c-adfb-84a0668fecbc | |
dc.identifier.citation | Vasou , A , Nightingale , K , Cetkovská , V , Scheler , J , Bamford , C G G , Andrejeva , J , Rowe , J C , Swatek , K N , Schwarz-Linek , U , Randall , R E , McLauchlan , J , Weekes , M P , Bogunovic , D & Hughes , D J 2025 , ' ISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans ' , European Journal of Immunology , vol. 55 , no. 2 , e202451651 . https://doi.org/10.1002/eji.202451651 | en |
dc.identifier.issn | 0014-2980 | |
dc.identifier.other | ORCID: /0000-0002-9304-6678/work/178723950 | |
dc.identifier.other | ORCID: /0000-0003-0526-223X/work/178724469 | |
dc.identifier.other | ORCID: /0000-0002-0090-5710/work/178724879 | |
dc.identifier.uri | https://hdl.handle.net/10023/31395 | |
dc.description | Funding: This work was supported by grants from the Academy of Medical Sciences (SBF003/1028 to DJH), Wellcome Trust Institutional Strategic Support Fund (to DJH), Wellcome Trust (101788/Z/13/Z to RER), the UK Medical Research Council (MC_UU_12014/1 to JM and CGGB) and by the Wellcome Trust via a Senior Clinical Research Fellowship (108070/Z/15/Z to MPW). The UK Medical Research Council (MC_UU_00038/8 to KNS). KNS is a Lister Institute Prize Fellow. | en |
dc.description.abstract | Type I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser. | |
dc.format.extent | 16 | |
dc.format.extent | 2840322 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Journal of Immunology | en |
dc.rights | © 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | en |
dc.subject | Autoinflammatory disease | en |
dc.subject | Interferon-stimulated genes | en |
dc.subject | Interferonopathy | en |
dc.subject | ISG15 | en |
dc.subject | Type I IFN signalling | en |
dc.subject | USP18 | en |
dc.subject | DAS | en |
dc.subject | MCC | en |
dc.title | ISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans | en |
dc.type | Journal article | en |
dc.contributor.sponsor | Academy of Medical Sciences | en |
dc.contributor.sponsor | The Wellcome Trust | en |
dc.contributor.institution | University of St Andrews.School of Biology | en |
dc.contributor.institution | University of St Andrews.Biomedical Sciences Research Complex | en |
dc.identifier.doi | 10.1002/eji.202451651 | |
dc.description.status | Peer reviewed | en |
dc.identifier.grantnumber | SBF003/1028 | en |
dc.identifier.grantnumber | 101788/Z/13/Z | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.